AIMC Topic: Thrombolytic Therapy

Clear Filters Showing 1 to 10 of 38 articles

Collaborative artificial intelligence for the diagnosis and management of acute ischemic stroke.

Annals of medicine
BACKGROUND: Acute Ischemic Stroke (AIS) remains a critical global health challenge that requires continuous improvement in diagnostic strategies. Timely and accurate diagnosis is essential for effective reperfusion therapies such as intravenous throm...

Development and Validation of a Web-Based Machine Learning Model for Predicting Early Neurological Deterioration Following Stroke Thrombolysis: Multicenter Study.

Journal of medical Internet research
BACKGROUND: Early neurological deterioration (END) significantly worsens outcomes in patients with acute ischemic stroke (AIS) receiving intravenous thrombolysis, yet clinicians lack reliable tools to identify high-risk patients who need intensified ...

Temporal shifts in prognostic factors for 90- and 180-day outcomes after stroke thrombolysis: A machine learning analysis.

PloS one
INTRODUCTION: Prognostication at 90 and 180 days after thrombolysis for acute ischemic stroke (AIS) is critical, yet the temporal evolution of key predictors remains inadequately understood. The utility of machine learning for systematically comparin...

Association between lipid profiles and early clinical outcomes in acute ischemic stroke: a single-center cohort study in the Chinese population.

BMC neurology
BACKGROUND: The clinical significance and contribution of the lipid profile in atherosclerosis are well established. However, further investigation is needed in stroke patients, particularly regarding apolipoprotein B100 (ApoB100), a novel non-tradit...

Metabolomic biomarkers could be molecular clocks in timing stroke onset.

Scientific reports
The preferred treatment for acute ischaemic stroke (AIS) is intravenous thrombolysis (IVT) administered within 4.5 hours (h) of symptom onset. This study aimed to identify metabolomic biomarkers for distinguishing AIS patients within 4.5 h of symptom...

A two-stage machine learning-based risk assessment model for intravenous thrombolysis in acute ischemic stroke (AIS): A multi-center modeling study of pooled datasets.

International journal of medical informatics
OBJECTIVE: Develop a two-stage, machine learning-based thrombolysis risk stratification model from existing medical datasets and electronic health records to predict the risk of early hemorrhagic transformation(HT) and in-hospital mortality(IM) follo...

Risk Factors and Outcomes of Hemorrhagic Transformation in Acute Ischemic Stroke Following Thrombolysis: Analysis of a Single-Center Experience and Review of the Literature.

Medicina (Kaunas, Lithuania)
: This is a retrospective study conducted at the Clinical County Hospital of Craiova, Romania, providing valuable insights into hemorrhagic transformation (HT) in thrombolyzed patients with acute ischemic stroke (AIS). Hemorrhagic complications remai...

Automated Identification of Stroke Thrombolysis Contraindications from Synthetic Clinical Notes: A Proof-of-Concept Study.

Cerebrovascular diseases extra
INTRODUCTION: Timely thrombolytic therapy improves outcomes in acute ischemic stroke. Manual chart review to screen for thrombolysis contraindications may be time-consuming and prone to errors. We developed and tested a large language model (LLM)-bas...

Rapid Blood Clot Removal via Remote Delamination and Magnetization of Clot Debris.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Micro/nano-scale robotic devices are emerging as a cutting-edge approach for precision intravascular therapies, offering the potential for highly targeted drug delivery. While employing micro/nanorobotics for stroke treatment is a promising strategy ...

Deep learning of noncontrast CT for fast prediction of hemorrhagic transformation of acute ischemic stroke: a multicenter study.

European radiology experimental
BACKGROUND: Hemorrhagic transformation (HT) is a complication of reperfusion therapy following acute ischemic stroke (AIS). We aimed to develop and validate a model for predicting HT and its subtypes with poor prognosis-parenchymal hemorrhage (PH), i...